Inventory, net

12 Months Ended

Dec. 31, 2024

Inventory, net

Inventory, net

5. Inventory, net

Inventories consist of the following:

	December 31, 2024		December 31, 2023
Raw materials	$	2,124	$	2,639
Work-in-process		291		708
		2,415		3,347
Less Inventory Reserve for Obsolescence		(1,515)		(526)
Total	$	900	$	2,821

As of December 31, 2024 and 2023, inventory balances include inventory costs subsequent to regulatory approval of KORSUVA injection on August 23, 2021. During the year ended December 31, 2024, the Company wrote down $2,963 of commercial supply inventory due to obsolescence.